EHS
EHS

New patent expiration for IPR drug CRESTOR – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent expiration for IPR drug CRESTOR


Annual Drug Patent Expirations for CRESTOR

Crestor is a drug marketed by IPR and is included in one NDA. It is available from four suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

CRESTOR drug price trends.

Drug patent litigation for CRESTOR.

The generic ingredient in CRESTOR is rosuvastatin calcium. Four suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for IPR drug CRESTOR



Source link

EHS
Back to top button